Fluoroquinolone- resistant mycobacterium tuberculosis, Pakistan, 2005-2009

Emerging Infectious Diseases

Volumn 17, Issue 3, 2011, Pages 564-566

  Jabeen, Kauser ^a   Shakoor, Sadia ^a   Chishti, Shazia ^a   Ayaz, Afsheen ^a   Hasan, Rumina ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; ETHAMBUTOL; ISONIAZID; OFLOXACIN; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONCENTRATION RESPONSE; DRUG RESISTANT TUBERCULOSIS; DRUG SENSITIVITY; INCIDENCE; LETTER; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PAKISTAN;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; HOSPITALS, UNIVERSITY; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PAKISTAN; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 79952339525     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1703.100957     Document Type: Letter

References (9)

1. Hasan R, Jabeen K, Mehraj V, Zafar F, Malik F, Hassan Q, et al. Trends of Mycobacterium tuberculosis (MTB) resistance over a period of 17 years from Pakistan. Int J Infect Dis. 2009;13:e377-e382.
2. Johnston JC, Shahidi NC, Sadatsafavi M, Fitzgerald JM. Treatment outcomes of multidrug resistant tuberculosis: a systematic review and meta-analysis. PLoS One. 2009;4:e6914. DOI: 10.1371/ journal.pone.0006914
3. World Health Organization. Multidrug and extensively drug-resistant TB (M/XDRTB). 2010 Global report on surveillance and response. WHO/HTM/TB/2010.3. Geneva: The Organization; 2010. p. 1-58.
4. Hasan R, Jabeen K, Ali A, Rafiq Y, Laiq R, Malik B, et al. Extensively drug-resistant tuberculosis, Pakistan. Emerg Infect Dis. 2010;16;1473-5.
5. Okeke IN, Laxminarayan R, Bhutta ZA, Duse AG, Jenkins P, O'Brien TF, et al. Antimicrobial resistance in developing countries. Part 1: recent trends and current status. Lancet Infect Dis. 2005;5:481-93. DOI: 10.1016/S1473-3099(05)70189-4
6. Agrawal D, Udwadia ZF, Rodriguez C, Mehta A. Increasing incidence of fl uoroquinolone-resistant Mycobacterium tuberculosis in Mumbai, India. Int J Tuberc Lung Dis. 2009;13:79-83.
7. Huang TS, Kunin CM, Lee SSJ, Chen YS, Tu HZ, Liu YC. Trends in fl uoroquinolone resistance of Mycobacterium tuberculosis complex in a Taiwanese medical centre: 1995-2003. J Antimicrob Chemother. 2005;56:1058-1062. DOI: 10.1093/jac/ dki353
8. Bozeman L, Burman W, Metchock B, Welch L, Weiner M; Tuberculosis Trials Consortium. Fluoroquinolone susceptibility among Mycobacterium tuberculosis isolates from the United States and Canada. Clin Infect Dis. 2005;40:386-91. DOI: 10.1086/427292
9. Butt ZA, Gilani AH, Nanan D, Sheikh AL, White F. Quality of pharmacies in Pakistan: A cross-sesctional survey. Int J Qual Health Care. 2005;17:307-13. DOI: 10.1093/intqhc/mzi049